Sugi Predict

Sugi Predict / Compounds / SCHEMBL102844

SCHEMBL102844

SCHEMBL102844

Nc1nc2c(F)cccc2s1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 7/20 1.00
▸ ALDH1A1 P00352 7/20 0.61
▸ LMNA P02545 5/20 0.61
▸ PDPK1 O15530 1/20 0.61
▸ PDE10A Q9Y233 1/20 0.61
▸ GAA P10253 5/20 0.61
▸ MAPT P10636 3/20 0.61
▸ RAB9A P51151 6/20 0.59
▸ NPC1 O15118 5/20 0.59
▸ MEN1 O00255 4/20 0.59
▸ HPGD P15428 4/20 0.59
▸ KMT2A Q03164 4/20 0.59
▸ KDM4E B2RXH2 3/20 0.59
▸ PRNP P04156 1/20 0.59
▸ TDP1 Q9NUW8 2/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ ILK Q13418 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL969167 0.79 ALDH1A1 (0.66) SMN1; SMN2ALDH1A1LMNAPDPK1PDE10A
SCHEMBL5892826 0.79 SMN1; SMN2 (0.66) SMN1; SMN2ALDH1A1LMNAGAAMAPT
Hydrochloric Acid SCHEMBL28787382 0.78 ALDH1A1 (0.63) SMN1; SMN2ALDH1A1LMNAPDPK1PDE10A
SCHEMBL3077601 0.78 SMN1; SMN2 (0.67) SMN1; SMN2ALDH1A1LMNAGAAMAPT
SCHEMBL24425191 0.77 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1LMNAPDPK1PDE10A
SCHEMBL30829728 0.77 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1LMNAPDPK1PDE10A
SCHEMBL31469938 0.77 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1LMNAPDPK1PDE10A
SCHEMBL30904497 0.76 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1LMNAPDPK1PDE10A
SCHEMBL2748639 0.76 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1LMNAPDPK1PDE10A
SCHEMBL2748892 0.76 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1LMNAPDPK1PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250163079-A1 KRAS INHIBITORS INCYTE CORPORATION 2025-05-22 — — US claimed
CN-118772080-A Antimycobacterial heterocyclic amides 克莱斯通公司 2024-10-15 — — CN claimed
CN-112423746-B Novel antimycobacterial heterocyclic amides 克莱斯通公司 2024-06-28 — — CN claimed
CN-107417705-A Imidazo [2,1 b] benzothiazole compound and its synthetic method 湘潭大学 2017-12-01 — — CN claimed
US-8889670-B2 Heterocyclic compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-18 — — US claimed
EP-2398771-A2 HETEROCYCLIC COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2011-12-28 — — EP claimed
WO-2010096371-A2 HETEROCYCLIC COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-08-26 — — WO claimed
US-20250197387-A1 BCL-XL DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2025-06-19 — — US disclosed
US-20250171438-A1 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS AGIOS PHARMACEUTICALS, INC. 2025-05-29 — — US disclosed
US-20250163079-A1 KRAS INHIBITORS INCYTE CORPORATION 2025-05-22 — — US disclosed
EP-4554580-A1 NEW ANTIBIOTIC COMPOUNDS Université Côte d'Azur (FR) 2025-05-21 — — EP disclosed
CN-117126578-B Organosilicon polymer/POSS hybrid antifouling coating grafted with antibacterial molecules and preparation method thereof 中国科学院海洋研究所 2025-04-22 — — CN disclosed
CN-119486733-A Novel antibiotic compounds 蔚蓝海岸大学 2025-02-18 — — CN disclosed
US-20020045615-A1 Benzothiazole derivatives with activity as adenosine receptor ligands F.HOFFMANN-LA ROCHE AG (CH) 2002-04-18 — — US disclosed
WO-2001097786-A2 BENZOTHIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2001-12-27 — — WO disclosed
CN-1043891-C Fluorobenzothiazolyloxyacetamides BAYER AG (DE) 1999-06-30 — — CN disclosed
US-5442074-A Sulfonyl containing fluorobenzothiazole as chemical intermediate BAYER AKTIENGESELLSCHAFT (DE) 1995-08-15 — — US disclosed
US-5356864-A New herbicidal fluorobenzothiazolyloxyacetamides BAYER AKTIENGESELLSCHAFT (DE) 1994-10-18 — — US disclosed
CN-1087903-A Fluoro benzothiazole oxygen yl acetamide BAYER AG (DE) 1994-06-15 — — CN disclosed
EP-0588183-A1 Fluoro benzothiazolyloxyacetamide BAYER AG (DE) 1994-03-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250163079-A1 KRAS INHIBITORS KRAS, NRAS, HRAS SMN1; SMN2 3572/4885ALDH1A1 2350/4885LMNA 2773/4885
US-20250197387-A1 BCL-XL DEGRADERS AND USES THEREOF XIAP, BCL2L1, BCL2L10 SMN1; SMN2 3396/4885ALDH1A1 4101/4885LMNA 2940/4885
US-20020045615-A1 Benzothiazole derivatives with activity as adenosine receptor ligands ADORA2A, ADORA1, ADORA3 SMN1; SMN2 3173/4885ALDH1A1 383/4885LMNA 3923/4885
US-20250171438-A1 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS PAH, KDM8, PHF8 SMN1; SMN2 1592/4885ALDH1A1 865/4885LMNA 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.